3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
48
Lymphoma, Large B-Cell, Diffuse
36
Multiple Myeloma
33
Burkitt Lymphoma
32
Lymphoma
30
Leukemia, Myeloid, Acute
29
Lymphoma, Non-Hodgkin
28
Recurrence
26
Breast Neoplasms
26
Lymphoma, B-Cell
23
Neoplasms
22
Myelodysplastic Syndromes
20
Lymphoma, Follicular
20
Leukemia, Lymphocytic, Chronic, B-Cell
20
Hodgkin Disease
17
Triple Negative Breast Neoplasms
16
Leukemia
16
Ovarian Neoplasms
15
Hematologic Neoplasms
15
Melanoma
14
Neuroblastoma
13
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
12
Lymphoma, Mantle-Cell
12
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
12
Pancreatic Neoplasms
11
Leukemia, Biphenotypic, Acute
10
Sarcoma
9
Neoplasm Metastasis
9
Lymphoma, B-Cell, Marginal Zone
9
Leukemia, Myelomonocytic, Chronic
9
Interventions
Specimen Handling
6
Human Papillomavirus DNA Tests
4
Colposcopy
4
Papillomavirus Vaccines
2
Human Papillomavirus Recombinant Vaccine nonavalent
2
Cisplatin
2
Carboplatin
2
toripalimab
1
epigallocatechin gallate
1
Transurethral Resection of Prostate
1
Standing Orders
1
Radiotherapy, Intensity-Modulated
1
Radiosurgery
1
Radiation
1
Platinum
1
Methods
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Educational Status
1
Early Intervention, Educational
1
Drug Therapy
1
Docetaxel
1
Clinical Protocols
1
Chemoradiotherapy
1
Bevacizumab
1
Benzethonium
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Papillomavirus Infections
×
Cyclophosphamide
×
90 days
×
Clear all
No trials found.